Northrop, A., Christofferson, A., Umashankar, S., Melisko, M., Castillo, P., Brown, T., Heditsian, D., Brain, S., Simmons, C., Hieken, T., Ruddy, K. J., Mainor, C., Afghahi, A., Tevis, S., Blaes, A., Kang, I., Asare, A., Esserman, L., Hershman, D. L., & Basu, A. (2024). Implementation and impact of an electronic patient reported outcomes system in a phase II multi-site adaptive platform clinical trial for early-stage breast cancer. Journal of the American Medical Informatics Association. https://doi.org/10.1093/jamia/ocae190

Casey, R. T., Hendriks, E., Deal, C., Waguespack, S. G., Wiegering, V., Redlich, A., Akker, S., Prasad, R., Fassnacht, M., Clifton-Bligh, R., Amar, L., Bornstein, S., Canu, L., Charmandari, E., Chrisoulidou, A., Freixes, M. C., de Krijger, R., de Sanctis, L., Fojo, A., … Pamporaki, C. (2024). International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents. Nature Reviews Endocrinology. https://doi.org/10.1038/s41574-024-01024-5

Mohty, R., Bazarbachi, A. H., Labopin, M., Esteve, J., Kröger, N., Cornelissen, J. J., Blaise, D., Socié, G., Maury, S., Ganser, A., Gedde-Dahl, T., von dem Borne, P., Bourhis, J. H., Bulabois, C. E., Yakoub-Agha, I., Pabst, C., Nguyen, S., Chevallier, P., Huynh, A., … Mohty, M. (2024). Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMT. Bone Marrow Transplantation. https://doi.org/10.1038/s41409-024-02384-2

Mejia Saldarriaga, M., Pan, D., Unkenholz, C., Mouhieddine, T. H., Velez-Hernandez, J. E., Engles, K., Fein, J. A., Monge, J., Rosenbaum, C., Pearse, R., Jayabalan, D., Gordillo, C., Chan, H. T., Yamshon, S., Thibaud, S., Mapara, M., Inghirami, G., Lentzsch, S., Reshef, R., … Bustoros, M. (2024). Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma. Blood Advances, 8(15), 3859–3869. https://doi.org/10.1182/bloodadvances.2023012470

Moise, K. J., Ling, L. E., Oepkes, D., Tiblad, E., Verweij, E. J. T. J., Lopriore, E., Smoleniec, J., Sachs, U. J., Bein, G., Kilby, M. D., Miller, R. S., Devlieger, R., Audibert, F., Emery, S. P., Markham, K., Norton, M. E., Ocón-Hernández, O., Pandya, P., Pereira, L., … Bussel, J. B. (2024). Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn. New England Journal of Medicine, 391(6), 526–537. https://doi.org/10.1056/nejmoa2314466

Serrano, D., Johansson, H., Bertelsen, B.-E., Gandini, S., Mellgren, G., Thomas, P., Crew, K. D., Kumar, N. B., Macis, D., Aristarco, V., Guerrieri-Gonzaga, A., Lazzeroni, M., D’Amico, M., Buttiron-Webber, T., Briata, I. M., Spinaci, S., Galimberti, V., Vornik, L. A., Villar-Sanchez, E., … DeCensi, A. (2024). Drug and biomarker tissue levels in a randomized presurgical trial on exemestane alternative schedules. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae183

Plumber, S. A., Tate, T., Al-Ahmadie, H., Chen, X., Choi, W., Basar, M., Lu, C., Viny, A., Batourina, E., Li, J., Gretarsson, K., Alija, B., Molotkov, A., Wiessner, G., Lee, B. H. L., McKiernan, J., McConkey, D. J., Dinney, C., Czerniak, B., & Mendelsohn, C. L. (2024). Rosiglitazone and trametinib exhibit potent anti-tumor activity in a mouse model of muscle invasive bladder cancer. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-50678-2

Sathe, C., Accordino, M. K., DeStephano, D., Shah, M., Wright, J. D., & Hershman, D. L. (2024). Disparities in PI3K/mTOR inhibitor use, toxicities, and outcomes among patients with metastatic breast cancer. Breast Cancer Research and Treatment, 206(3), 519–526. https://doi.org/10.1007/s10549-024-07337-3

Muchtar, E., Wisniowski, B., Geyer, S., Palladini, G., Milani, P., Merlini, G., Schönland, S., Veelken, K., Hegenbart, U., Leung, N., Dispenzieri, A., Kumar, S. K., Kastritis, E., Dimopoulos, M. A., Liedtke, M., Ulloa, P., Sanchorawala, V., Szalat, R., Dooley, K., … Gertz, M. A. (2024). Graded Organ Response and Progression Criteria for Kidney Immunoglobulin Light Chain Amyloidosis. JAMA Oncology. https://doi.org/10.1001/jamaoncol.2024.2629

Kinslow, C. J., Kim, A., Rohde, C. H., Sanchez, G. I., Yu, J. B., Kim, D. K., Lowe, L. S., Kachnic, L. A., Cheng, S. K., Crew, K. D., Neugut, A. I., & Horowitz, D. P. (2024). Systematic under-ascertainment of anaplastic large cell lymphoma cases in cancer registries: report from a comprehensive cancer center. Journal of Plastic, Reconstructive & Aesthetic Surgery, 95, 49–51. https://doi.org/10.1016/j.bjps.2024.05.058

David, A. F., Heinzel, A., Kammer, M., Aschauer, C., Reindl-Schwaighofer, R., Hu, K., Chen, H.-S., Muckenhuber, M., Kubetz, A., Weijler, A. M., Worel, N., Edinger, M., Berlakovich, G., Lion, T., Sykes, M., Wekerle, T., & Oberbauer, R. (2024). Combination cell therapy leads to clonal deletion of donor-specific T cells in kidney transplant recipients. EBioMedicine, 106, 105239. https://doi.org/10.1016/j.ebiom.2024.105239

Wolfson, J. A., Davis, E. S., Saha, A., Martinez, I., McCall, D., Kothari, P., Brackett, J., Dickens, D. S., Kahn, A. R., Schwalm, C., Sharma, A., Richman, J., Cuglievan, B., Bhatia, S., Dai, C., Levine, J. M., & Johnston, E. E. (2024). Adolescents and young adults with cancer: the clinical course of COVID-19 infections. JNCI: Journal of the National Cancer Institute, 116(8), 1366–1373. https://doi.org/10.1093/jnci/djae085

Wang, W., Zhang, W., Su, L., Liu, L., Gao, Y., Wang, Q., Su, H., Song, Y., Zhang, H., Shen, J., Jing, H., Wang, S., Cen, X., Liu, H., Liu, A., Li, Z., Luo, J., He, J., Wang, J., … Zhou, D. (2024). Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in China. Annals of Hematology, 103(8), 3061–3069. https://doi.org/10.1007/s00277-024-05708-w

Rosenberg, S. M., Zeng, C., An, A., Ssebyala, S. N., Stein, T., Lombardo, G., Walker, D., Mercurio, A. M., Elreda, L., Taiwo, E., Hershman, D. L., & Pinheiro, L. C. (2024). Characterizing “collateral damage” in men and women with metastatic breast cancer (mBC) from diverse racial and ethnic backgrounds in New York City. Breast Cancer Research and Treatment, 207(1), 129–141. https://doi.org/10.1007/s10549-024-07347-1

Luthria, K., Shah, P., Caldwell, B., Melms, J. C., Abuzaid, S., Jakubikova, V., Brodtman, D. Z., Bose, S., Amin, A. D., Ho, P., Biermann, J., Tagore, S., Ingham, M., Schwartz, G. K., & Izar, B. (2024). Single-cell profiling of sarcomas from archival tissue reveals programs associated with resistance to immune checkpoint blockade. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-23-2976

Basu, A., & Hershman, D. L. (2024). The “PRO”mise and “PRO”gress of PROs in cancer clinical trials. JNCI: Journal of the National Cancer Institute, 116(10), 1544–1546. https://doi.org/10.1093/jnci/djae157

Sathe, C., Raghunathan, R., Ulene, S., McAuley, F., Bhatt, K. A., McGuinness, J. E., Trivedi, M. S., Vasan, N., Kalinsky, K. M., Crew, K. D., Faheem, K. F., Harden, E., Law, C., Hershman, D. L., & Accordino, M. K. (2024). Use of a Smartphone Application to Promote Adherence to Oral Medications in Patients With Breast Cancer. JCO Oncology Practice. https://doi.org/10.1200/op.24.00187

Pike, L. R. G., Miao, E., Boe, L. A., Patil, T., Imber, B. S., Myall, N. J., Pollom, E. L., Hui, C., Qu, V., Langston, J., Chiang, V., Grant, M., Goldberg, S. B., Palmer, J. D., Prasad, R. N., Wang, T. J. C., Lee, A., Shu, C. A., Chen, L. N., … Rusthoven, C. G. (2024). Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From EGFR and ALK Oncogene–Driven Non–Small Cell Lung Cancer (TURBO-NSCLC). Journal of Clinical Oncology. https://doi.org/10.1200/jco.23.02668

Kota, K. P., Trakht, I., Kalantarov, G., Ordonez, D., Wei, J., Trefry, S., Bavari, E., Richardson, J., Zamani, R., Raney, C., Nasar, F., Daugherty, B., Lederman, S., & Bavari, S. (2024). High-Throughput Screening Assay for Convalescent Sera in COVID-19: Efficacy, Donor Selection, and Variant Neutralization. Microorganisms, 12(8), 1503. https://doi.org/10.3390/microorganisms12081503

Suzuki, Y., Ferris, J. S., Chen, L., Dioun, S., Usseglio, J., Matsuo, K., Xu, X., Hershman, D. L., & Wright, J. D. (2024). Fertility-preserving treatment for stage IA endometrial cancer: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology. https://doi.org/10.1016/j.ajog.2024.07.018

Karvonen, H., & Vasan, N. (2024). Therapeutic potential of inhibiting the PI3Kγ complex for leukemia. Cell Chemical Biology, 31(7), 1244–1246. https://doi.org/10.1016/j.chembiol.2024.06.009

Roh, D. J., Poyraz, F. C., Mao, E., Shen, Q., Kansara, V., Cottarelli, A., Song, S., Nemkov, T., Kumar, A., Hudson, K. E., Ghoshal, S., Park, S., Agarwal, S., Connolly, E. S., Claassen, J., Kreuziger, L. B., Hod, E., Yeatts, S., Foster, L. D., & Selim, M. (2024). Anemia From Inflammation After Intracerebral Hemorrhage and Relationships With Outcome. Journal of the American Heart Association, 13(14). https://doi.org/10.1161/jaha.124.035524

Bergstein, A., Huang, Y., Hershman, D. L., Xu, X., & Wright, J. (2024). Impact of medicaid expansion on cervical cancer screening: A state-specific difference in difference analysis. Gynecologic Oncology, 189, 49–55. https://doi.org/10.1016/j.ygyno.2024.06.028

Fu, J., Hsiao, T., Waffarn, E., Meng, W., Long, K. D., Frangaj, K., Jones, R., Gorur, A., Shtewe, A., Li, M., Muntnich, C. B., Rogers, K., Jiao, W., Velasco, M., Matsumoto, R., Kubota, M., Wells, S., Danzl, N., Ravella, S., … Sykes, M. (2024). Dynamic establishment and maintenance of the human intestinal B cell population and repertoire following transplantation in a pediatric-dominated cohort. Frontiers in Immunology, 15. https://doi.org/10.3389/fimmu.2024.1375486

Merl, S., Chen, B., Gunes, M. E., Atta, H., Yang, K., Ekanayake-Alper, D., Hajosi, D., Huang, F., Bhola, B., Patwardhan, S., Jordache, P., Nowak, G., Martinez, M., Kato, T., Sykes, M., Yamada, K., & Weiner, J. (2024). Development of a large animal orthotopic intestinal transplantation model with long-term survival for study of immunologic outcomes. Frontiers in Transplantation, 3. https://doi.org/10.3389/frtra.2024.1367486

LANG, F. M., TERUYA, S., CUOMO, M., SANTOS, A. M., RADHAKRISHNAN, J., LENTZSCH, S., CHAKRABORTY, R., BHUTANI, D., & MAURER, M. S. (2024). Safety and Efficacy of SGLT2 Inhibitors for Amyloid Light-Chain Cardiomyopathy. Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2024.06.009

DeFilipp, Z., Kim, H. T., Spyrou, N., Katsivelos, N., Kowalyk, S., Eng, G., Kasikis, S., Beheshti, R., Baez, J., Akahoshi, Y., Ayuk, F., Choe, H., Etra, A., Grupp, S. A., Hexner, E. O., Hogan, W. J., Kitko, C. L., Qayed, M., Reshef, R., … Chen, Y.-B. (2024). The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD. Blood Advances, 8(13), 3488–3496. https://doi.org/10.1182/bloodadvances.2024012561

Ramachandran, R., Shah, D., Luo, C., Shah, V., Cliff, E. R. S., Sanchorawala, V., Lentzsch, S., & Chakraborty, R. (2024). The clinical trials landscape in immunoglobulin light chain amyloidosis: a systematic review. Blood Advances, 8(13), 3464–3467. https://doi.org/10.1182/bloodadvances.2024012737

Nguyen, T. T. T., Gao, Q., Mun, J.-Y., Zhu, Z., Shu, C., Naim, A., Rogava, M., Izar, B., Westhoff, M.-A., Karpel-Massler, G., & Siegelin, M. D. (2024). Suppressing PD-L1 Expression via AURKA Kinase Inhibition Enhances Natural Killer Cell-Mediated Cytotoxicity against Glioblastoma. Cells, 13(13), 1155. https://doi.org/10.3390/cells13131155

Akahoshi, Y., Spyrou, N., Weber, D., Aguayo-Hiraldo, P., Ayuk, F. A., Chanswangphuwana, C., Choe, H. K., Eder, M., Etra, A. M., Grupp, S. A., Hexner, E. O., Hogan, W. J., Kitko, C. L., Kraus, S., Al Malki, M. M., Merli, P., Qayed, M., Reshef, R., Schechter, T., … Ferrara, J. L. M. (2024). Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD. Blood Journal. https://doi.org/10.1182/blood.2024025106

Fojo, A. T., & Labadie, B. (2024). Harvesting information from Kaplan-Meier plots: part 1—detecting censoring. The Oncologist, 29(7), 551–553. https://doi.org/10.1093/oncolo/oyae070

Akpan, I. J., Bogyo, K., Leeman-Neill, R. J., Wattacheril, J., & Francis, R. O. (2024). Congenital dyserythropoietic anemia type II and ineffective erythropoiesis: challenges in diagnosis and management. Frontiers in Hematology, 3. https://doi.org/10.3389/frhem.2024.1389820

Marín-Chollom, A. M., Rillamas-Sun, E., Koch, P. A., Contento, I. R., Gaffney, A. O., Ulanday, K. T., Hershman, D. L., & Greenlee, H. (2024). Social Support, Diet, and Physical Activity among Latina/Hispanic Women Breast Cancer Survivors. Journal of Immigrant and Minority Health. https://doi.org/10.1007/s10903-024-01614-5

Huang, Y.-H., Yoon, C. H., Gandhi, A., Hanley, T., Castrillon, C., Kondo, Y., Lin, X., Kim, W., Yang, C., Driouchi, A., Carroll, M., Gray-Owen, S. D., Wesemann, D. R., Drake, C. G., Bertagnolli, M. M., Beauchemin, N., & Blumberg, R. S. (2024). High-dimensional mapping of human CEACAM1 expression on immune cells and association with melanoma drug resistance. Communications Medicine, 4(1). https://doi.org/10.1038/s43856-024-00525-8

Orleni, M., Parise, R. A., Holleran, J. L., Amengual, J. E., Feng, Y., Synold, T., & Beumer, J. H. (2024). Quantitation of tazemetostat in human plasma using liquid chromatography–tandem mass spectrometry. Biomedical Chromatography, 38(7). Portico. https://doi.org/10.1002/bmc.5903

Perzanowski, M. S., Rauh, V., Ramphal, B., Acosta, L., Hoepner, L., Rundle, A. G., Perera, F. P., Herbstman, J., Miller, R. L., & Margolis, A. E. (2024). Rhinorrhea and watery eyes in infancy and risk of attention‐deficit hyperactivity disorder in school‐age children. Developmental Psychobiology, 66(5). Portico. https://doi.org/10.1002/dev.22497

Utomo, R., McWatt, S. C., Talis, A., Xiao, Q. Y., Saraci, K., Waschke, J., Sigmund, A. M., Gill Sagoo, M., Wingate, R., Brassett, C., Chien, C.-L., Traxler, H., Sakurai, T., Zeroual, M., Olsen, J., El-Batti, S., Viranta-Kovanen, S., Yamada, Y., Keay, K. A., … Wu, A. (2023). Health profession students’ outlooks on the medical profession during the COVID-19 pandemic: a global perspective. Journal of Communication in Healthcare, 17(2), 154–168. https://doi.org/10.1080/17538068.2023.2214391

Henick, B. S., & Moy, R. H. (2024). TAPping Into PD-L1 Testing Efficiency for Gastroesophageal Cancer. JCO Precision Oncology, 8. https://doi.org/10.1200/po.24.00344

Cicero, K. I., Dlamini, X., Mavengere, Y., Justman, J., Nuwagaba-Biribonwoha, H., Dlamini, S., Dlamini, M., Ngwenyama, S., Ngcamphalala, C., Low, A., Philip, N. M., El-Sadr, W. M., Sahabo, R., Abreha, T., Temesgen, S., Mahlalela, N., Chiuzan, C., Chen, Y., Pan, S. S., … Neugut, A. I. (2024). Prevalence of monoclonal gammopathy of undetermined significance in Eswatini: a population-based study in Africa. JNCI Cancer Spectrum, 8(4). https://doi.org/10.1093/jncics/pkae056

Kinslow, C. J., Roy, S., Iwamoto, F. M., Brown, P. D., DeStephano, D. M., Canoll, P. D., Qureshi, S. S., Gallito, M., Sisti, M. B., Bruce, J. N., Horowitz, D. P., Kachnic, L. A., Neugut, A. I., Yu, J. B., Mehta, M. P., Cheng, S. K., & Wang, T. J. C. (2024). The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomas. Neuro-Oncology. https://doi.org/10.1093/neuonc/noae102

Patel, A. A., Yoon, J. J., Johnston, H., Davidson, M. B., Shallis, R. M., Chen, E. C., Burkart, M., Oh, T. S., Iyer, S. G., Madarang, E., Muthiah, C., Gross, I., Dean, R., Kassner, J., Viswabandya, A., Madero-Marroquin, R., Rampal, R. K., Guru Murthy, G. S., Bradley, T., … Odenike, O. (2024). Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era. Blood Advances, 8(13), 3468–3477. https://doi.org/10.1182/bloodadvances.2024012880

Durot, E., Roos-Weil, D., Chauchet, A., Decroocq, J., Di Blasi, R., Gastinne, T., Bensaber, H., Cheminant, M., Jacquet, C., Guidez, S., Gros, F.-X., Bachy, E., Coste, A., Cony-Makhoul, P., Treon, S. P., Delmer, A., Reshef, R., Le Gouill, S., Castillo, J. J., & Houot, R. (2024). High efficacy of CD19 CAR T cells in patients with transformed Waldenström macroglobulinemia. Blood, 143(26), 2804–2807. https://doi.org/10.1182/blood.2024024452

Trivanović, D., Vujačić, M., Labella, R., Djordjević, I. O., Ćazić, M., Chernak, B., & Jauković, A. (2024). Molecular Deconvolution of Bone Marrow Adipose Tissue Interactions with Malignant Hematopoiesis: Potential for New Therapy Development. Current Osteoporosis Reports. https://doi.org/10.1007/s11914-024-00879-x

Jamison, J. K., Zhou, M., Gelmann, E. P., Luk, L., Bates, S. E., Califano, A., & Fojo, T. (2024). Entinostat in patients with relapsed or refractory abdominal neuroendocrine tumors. The Oncologist. https://doi.org/10.1093/oncolo/oyae118

Bumma, N., Richter, J., Jagannath, S., Lee, H. C., Hoffman, J. E., Suvannasankha, A., Zonder, J. A., Shah, M. R., Lentzsch, S., Baz, R., Maly, J. J., Namburi, S., Pianko, M. J., Ye, J. C., Wu, K. L., Silbermann, R., Min, C.-K., Vekemans, M.-C., Munder, M., … Dhodapkar, M. V. (2024). Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma. Journal of Clinical Oncology, 42(22), 2702–2712. https://doi.org/10.1200/jco.24.01008

Etra, A., El Jurdi, N., Katsivelos, N., Kwon, D., Gergoudis, S., Morales, G., Spyrou, N., Kowalyk, S., Aguayo-Hiraldo, P., Akahoshi, Y., Ayuk, F., Baez, J., Betts, B. C., Chanswangphuwana, C., Chen, Y.-B., Choe, H., DeFilipp, Z., Gleich, S., Hexner, E., … Holtan, S. (2024). Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD. Blood Advances, 8(12), 3284–3292. https://doi.org/10.1182/bloodadvances.2023011049

Lu, Z., Wang, Y., Assumpção, A. L. F. V., Liu, P., Kopp, A., Saka, S., Mcilwain, S. J., Viny, A. D., Brand, M., & Pan, X. (2024). Yin Yang 1 regulates cohesin complex protein SMC3 in mouse hematopoietic stem cells. Blood Advances, 8(12), 3076–3091. https://doi.org/10.1182/bloodadvances.2023011411

Yu, H., Nishio, H., Barbi, J., Mitchell-Flack, M., Vignali, P. D., Zheng, Y., Lebid, A., Chang, K.-Y., Fu, J., Higgins, M., Huang, C.-T., Zhang, X., Li, Z., Blosser, L., Tam, A., Drake, C., & Pardoll, D. (2024). Neurotrophic factor Neuritin modulates T cell electrical and metabolic state for the balance of tolerance and immunity. ELife, 13. CLOCKSS. https://doi.org/10.7554/elife.96812

Nikiforow, S., Whangbo, J. S., Reshef, R., Tsai, D. E., Bunin, N., Abu-Arja, R., Mahadeo, K. M., Weng, W.-K., Van Besien, K., Loeb, D., Nasta, S. D., Nemecek, E. R., Zhao, W., Sun, Y., Galderisi, F., Wahlstrom, J., Mehta, A., Gamelin, L., Dinavahi, R., & Prockop, S. (2024). Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol. Blood Advances, 8(12), 3001–3012. https://doi.org/10.1182/bloodadvances.2023011626

Roeker, L. E., Woyach, J. A., Cheah, C. Y. Y., Coombs, C. C., Shah, N. N., Wierda, W. G., Patel, M. R., Lamanna, N., Tsai, D. E., Nair, B. C., Wang, C., Zhao, X., Liu, D., Radtke, D., Chapman, S., Marella, N., McNeely, S. C., & Brown, J. R. (2024). Fixed-Duration Pirtobrutinib plus Venetoclax with or without Rituximab in Relapsed/Refractory CLL: Phase 1b BRUIN Trial. Blood Journal. https://doi.org/10.1182/blood.2024024510